Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,
GlobeNewswireMar 25 08:50 ET
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference
JERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,
GlobeNewswireFeb 26 08:30 ET
Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans
Yahoo FinanceFeb 23 08:46 ET
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Most Popular Amongst Retail Investors Who Own 58%, Insiders Hold 22%
Yahoo FinanceJan 13 08:47 ET
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- The overview presentation will review some of the Company's recent achievements, including highly promising interim results from the Company's pancreatic cancer safety and feasibility trial as well
GlobeNewswireDec 20, 2023 09:15 ET
Alpha Tau to Participate in Sidoti Small-Cap Conference
JERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,
GlobeNewswireNov 29, 2023 08:30 ET
Alpha Tau to Participate in November Investor Conferences
JERUSALEM, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,
GlobeNewswireNov 1, 2023 08:30 ET
Alpha Tau Medical to Participate in September Investor Conferences
Globe NewswireAug 24, 2023 08:00 ET
Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023
JERUSALEM, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,
GlobeNewswireAug 2, 2023 09:00 ET
Alpha Tau Medical to Participate in June Investor Conferences
Globe NewswireMay 24, 2023 16:01 ET
Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Down 8.7% in April
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) was the recipient of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 11,600 shares, a dro
kopsourceMay 3, 2023 16:41 ET
Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day
JERUSALEM, May 03, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, t
GlobeNewswireMay 3, 2023 16:08 ET
Alpha Tau Medical (NASDAQ:DRTSW) Stock Price Up 12.4%
Shares of Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) rose 12.4% during trading on Thursday . The stock traded as high as $0.25 and last traded at $0.25. Approximately 975 shares were traded d
Defense WorldApr 21, 2023 02:55 ET
Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit
JERUSALEM, March 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT,
GlobeNewswireMar 29, 2023 16:01 ET
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Declines By 10.4%
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) was the target of a significant decrease in short interest in February. As of February 15th, there was short interest totalling 12,000 shares, a dec
Financial News LiveMar 7, 2023 18:22 ET
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Decreases By 24.1%
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) saw a large decrease in short interest in December. As of December 30th, there was short interest totalling 28,700 shares, a decrease of 24.1% from
kopsourceJan 21, 2023 23:11 ET
Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update
Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 37,
Defense WorldDec 31, 2022 02:11 ET
Alpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event During J.P. Morgan Healthcare Conference in San Francisco in January 2023
JERUSALEM, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau," or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,
GlobeNewswireDec 13, 2022 08:06 ET
Alpha Tau to Present at Upcoming November Investor Conferences
JERUSALEM, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau", or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,
GlobeNewswireNov 9, 2022 08:07 ET
Alpha Tau Director Gives up Board Seat to Take up Chief Commercial Officer Role
Alpha Tau Medical (NASDAQ:DRTS) appointed Peter Melnyk as Chief Commercial Officer (CCO). Melnyk resigned from Alpha's board to assume the full-time position as CCO, the Israeli cancer drug company sa
Seeking AlphaSep 2, 2022 06:07 ET
No Data
No Data